Diversity in clinical trials benefits everyone in ways that cannot be overlooked. Here’s a look at some of the history that has led to distrust, the importance of clinical trial diversity, creating lifelines for marginalized patients, and helping patients to access tomorrow’s medicine today.

Decentralized clinical trials offer many advantages over traditional clinical trial models, but what are DCTs exactly? Here’s a look at clinical trials and BIPOC patients, DCTs, and what decentralized clinical trials can mean for BIPOC patients. 

Diversity in clinical trials has been a topic of interest at Diverse Health Hub (DHH). Increasing diversity in clinical trials helps investigators to further improve and refine treatments for underrepresented patient groups. Here’s a look at U.S. efforts for improvements in enhancing clinical trial diversity.

Female, BIPOC, and LGBTQ groups are under-represented in clinical trials. Learn where things stand with gender and other disparities in clinical trials and how to make improvements.

Clinical trials are a vital component of research for cancer treatments and other medical conditions. We connected with Dr. Leanne Woods-Burnham about a recent commentary on the role of diverse populations in U.S. clinical trials.

Racial and ethnic minority groups (REMGs) will make up the majority of the population in the near future. This is problematic because present inequities render REMGs disproportionately vulnerable and sick.